09:39 EDT Kyverna Therapeutics Inc trading resumes
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on KYTX:
- Kyverna Therapeutics Showcases CAR T-cell Therapy Progress at EULAR
- J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks
- Kyverna Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
- Kyverna Therapeutics reports Q1 EPS ($1.12), consensus (84c)
- Kyverna Therapeutics added to Analyst Focus List at JPMorgan